Gyn Cancers: HCP Insights

CE / CME

Achieving Equitable Care in Gynecologic Cancers: Healthcare Professional Insights for Improving Care

Pharmacists: 0.75 contact hour (0.075 CEUs)

Nurses: 0.75 Nursing contact hour

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Released: August 09, 2023

Expiration: August 08, 2024

Maria Avila-Wallace
Maria Avila-Wallace, NP
Eloise Chapman-Davis
Eloise Chapman-Davis, MD, FACOG
Eva Y. Pan
Eva Y. Pan, PharmD, BCOP
Ritu Salani
Ritu Salani, MD, MBA

Activity

Progress
1
Course Completed

References

  • National Comprehensive Cancer Network. Clinical practice guidelines in oncology: endometrial cancer. v.2.2023. nccn.org. Accessed July 27, 2023.
  • Dostarlimab [prescribing information]. Durham, NC: GlaxoSmithKline; 2023.
  • Pembrolizumab [prescribing information]. Whitehouse Station, NJ: Merck & Co; 2021.
  • Lenvatinib [prescribing information]. Nutley, NJ: Eisai; 2022.
  • Paluch-Shimon S, Cardoso F, Sessa C, et al; ESMO Guidelines Committee. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann Oncol. 2016;27(suppl 5):v103-v110.
  • Starobova H, Vetter I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci. 2017;10:174. 
  • Konstantinopoulos PA, Ceccaldi R, Shapiro GI, et al. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer. Cancer Discov. 2015;5:1137-1154.
  • American Cancer Society. Risk factors for cervical cancer. cancer.org/cancer/cervical-cancer/causes-risks-prevention/risk-factors. Accessed July 27, 2023. 
  • US Centers for Disease Control and Prevention. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm. Accessed July 27, 2023.
  • KFF. kff.org. Accessed July 27, 2023.
  • ACOG Practice Bulletin No. 147: Lynch syndrome. Obstet Gynecol. 2014;124:1042-1054. 
  • Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68:698-702.
  • Kim JJ, Simms KT, Killen J, et al. Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: a cost-effectiveness analysis. PLoS Med. 2021;18:e1003534.
  • Kurosawa M, Sekine M, Yamaguchi M, et al. Long-term effects of human papillomavirus vaccination in clinical trials and real-world data: a systemic review. Vaccines (Basel). 2022;10:256.
  • Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70:321-346.
  • American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines. Accessed July 27, 2023. 
  • Makker V, Colombo N, Herráez AC, et al. Lenvatinib plus pembrolizumab for advanced endometrial cancer. N Engl J Med. 2022;386:437-448.
  • LaFargue CJ, Dal Molin GZ, Sood AK, et al. Exploring and comparing adverse events between PARP inhibitors. Lancet Oncol. 2019;20:e15-e28. 
  • Niraparib [prescribing information]. Durham, NC: GlaxoSmithKline; 2023. 
  • Olaparib [prescribing information]. Wilmington, DE: AstraZeneca; 2023. 
  • Rucaparib [prescribing information]. Boulder, CO: Clovis Oncology; 2016. 
  • Tisotumab vedotin [prescribing information]. Bothell, WA and Plainsboro, NJ: Seagen and Genmab US; 2023.